Oxford Global are proud to present our 4th Annual Biosimilars & Biobetters Congress, taking place on the 18th & 19th April 2016 in London. This unmissable event will address key topics in development and commercial issues including emerging markets, interchangeability, and development case studies. The biosimilars industry is experiencing major growth internationally and new regions are rapidly entering the biosimilars and biobetters market, making this an exciting time in terms of both challenges and opportunities for the industry.
Co-located with our 9th Annual Proteins and Antibodies Congress and 3rd Annual Peptides Congress, this two day conference brings together 400 senior global biologics experts and solution providers to discuss the current landscape of the industry, including representatives from Merck Serono, Biogen Idec, Abbvie, Boehringer Ingelheim, and Sanofi.
For more information or for the latest updates you can follow us on Twitter @BioSimCongress and join the Congress conversation on #PPB2016.